TNF Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
TNF Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2024.
  • TNF Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.93M, a 148% decline year-over-year.
  • TNF Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$23.7M, a 340% decline year-over-year.
  • TNF Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4M, a 73.7% increase from 2022.
  • TNF Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$15.2M, a 49.2% increase from 2021.
  • TNF Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$29.9M, a 215% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$23.7M -$1.93M -$5.97M -148% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$17.7M -$9.57M -$5.4M -130% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$12.3M -$9.8M -$8.29M -548% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$4M -$2.36M +$1.38M +36.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$5.38M $4.04M +$7.74M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$13.1M -$4.17M -$532K -14.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$12.6M -$1.51M +$2.61M +63.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$15.2M -$3.75M -$506K -15.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$14.7M -$3.69M +$1.77M +32.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$16.5M -$3.64M +$14.5M +79.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$30.9M -$4.12M -$1.03M -33.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$29.9M -$3.24M +$929K +22.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$30.8M -$5.47M -$2.23M -68.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$28.6M -$18.1M -$17M -1552% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$11.6M -$3.09M -$2.11M -215% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$9.49M -$4.17M -$2.83M -211% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$6.66M -$3.24M -$2.4M -287% Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-11-15
Q2 2020 -$4.25M -$1.09M -$300K -37.7% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-11-15
Q1 2020 -$3.95M -$982K -$65K -7.09% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-11-15
Q4 2019 -$3.89M -$1.34M +$2.5M +65.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$6.39M -$837K +$2.25M +72.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$8.63M -$795K +$1.27M +61.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$9.91M -$917K +$943K +50.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$10.8M -$3.84M +$184K +4.57% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$11M -$3.08M -$1.91M -162% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$9.13M -$2.07M -$1.25M -153% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$7.88M -$1.86M -$511K -37.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$7.37M -$4.02M -$2.93M -267% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$4.44M -$1.18M -$1.49M -480% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$2.95M -$818K +$191K +18.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$3.14M -$1.35M +$160K +10.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-07-13
Q4 2016 -$3.3M -$1.1M +$2.48M +69.4% Oct 1, 2016 Dec 31, 2016 10-K/A 2018-07-13
Q3 2016 -$5.78M $310K +$2.64M Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-07-13
Q2 2016 -$8.42M -$1.01M +$1.08M +51.6% Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-07-13
Q1 2016 -$9.5M -$1.51M -$187K -14.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$9.31M -$3.58M -$2.66M -292% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-11
Q3 2015 -$6.65M -$2.33M -$1.2M -107% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$5.44M -$2.09M -$1.58M -308% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$3.87M -$1.32M -$726K -122% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$3.14M -$912K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$1.12M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$511K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-18
Q1 2014 -$596K -$656K -1087% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q1 2013 $60.4K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.